Journal article icon

Journal article

Post-marketing regulation of medicines withdrawn from the market because of drug-attributed deaths: An analysis of justification.

Abstract:

Introduction

Several medicinal products have been withdrawn from the market because of drug-attributed deaths. However, there has been no investigation of whether such withdrawals were justified, and the extent to which confirmatory studies are used to investigate drug-adverse event relationships when deaths are reported is uncertain. We documented medicinal products withdrawn from the market because of drug-attributed deaths, identified confirmatory studies investigating the dru...

Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Files:
Publisher copy:
10.1007/s40264-017-0515-4

Authors


More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Primary Care Health Sciences
Role:
Author
More by this author
Institution:
University of Oxford
Division:
Societies, Other & Subsidiary Companies
Department:
Kellogg College
Oxford college:
Kellogg College
Role:
Author
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Primary Care Health Sciences
Role:
Author
More from this funder
Funding agency for:
Onakpoya, I
Grant:
Clarendon Fund
Publisher:
Springer Publisher's website
Journal:
Drug Safety Journal website
Volume:
40
Issue:
5
Pages:
431–441
Publication date:
2017-02-01
Acceptance date:
2017-02-13
DOI:
ISSN:
1179-1942
Source identifiers:
683741
Language:
English
Keywords:
Pubs id:
pubs:683741
UUID:
uuid:aed0ea3e-35c5-416a-af61-3a1e850c5a6e
Local pid:
pubs:683741
Deposit date:
2017-03-08

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP